These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

298 related items for PubMed ID: 28827418

  • 1. Effects of Echinocandins in Combination with Nikkomycin Z against Invasive Candida albicans Bloodstream Isolates and the fks Mutants.
    Cheung YY, Hui M.
    Antimicrob Agents Chemother; 2017 Nov; 61(11):. PubMed ID: 28827418
    [Abstract] [Full Text] [Related]

  • 2. The Gastrointestinal Tract Is a Major Source of Echinocandin Drug Resistance in a Murine Model of Candida glabrata Colonization and Systemic Dissemination.
    Healey KR, Nagasaki Y, Zimmerman M, Kordalewska M, Park S, Zhao Y, Perlin DS.
    Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 28971865
    [Abstract] [Full Text] [Related]

  • 3. Pyrosequencing to detect mutations in FKS1 that confer reduced echinocandin susceptibility in Candida albicans.
    Wiederhold NP, Grabinski JL, Garcia-Effron G, Perlin DS, Lee SA.
    Antimicrob Agents Chemother; 2008 Nov; 52(11):4145-8. PubMed ID: 18794385
    [Abstract] [Full Text] [Related]

  • 4. Accuracy of Sensititre YeastOne echinocandins epidemiological cut-off values for identification of FKS mutant Candida albicans and Candida glabrata: a ten year national survey of the Fungal Infection Network of Switzerland (FUNGINOS).
    Kritikos A, Neofytos D, Khanna N, Schreiber PW, Boggian K, Bille J, Schrenzel J, Mühlethaler K, Zbinden R, Bruderer T, Goldenberger D, Pfyffer G, Conen A, Van Delden C, Zimmerli S, Sanglard D, Bachmann D, Marchetti O, Lamoth F, Fungal Infection Network of Switzerland (FUNGINOS).
    Clin Microbiol Infect; 2018 Nov; 24(11):1214.e1-1214.e4. PubMed ID: 29909005
    [Abstract] [Full Text] [Related]

  • 5. Biofilm Production and Antibiofilm Activity of Echinocandins and Liposomal Amphotericin B in Echinocandin-Resistant Yeast Species.
    Marcos-Zambrano LJ, Gómez-Perosanz M, Escribano P, Zaragoza O, Bouza E, Guinea J.
    Antimicrob Agents Chemother; 2016 Jun; 60(6):3579-86. PubMed ID: 27021323
    [Abstract] [Full Text] [Related]

  • 6. Synergistic effect of nikkomycin Z with caspofungin and micafungin against Candida albicans and Candida parapsilosis biofilms.
    Kovács R, Nagy F, Tóth Z, Bozó A, Balázs B, Majoros L.
    Lett Appl Microbiol; 2019 Oct; 69(4):271-278. PubMed ID: 31385615
    [Abstract] [Full Text] [Related]

  • 7. Differential in vivo activities of anidulafungin, caspofungin, and micafungin against Candida glabrata isolates with and without FKS resistance mutations.
    Arendrup MC, Perlin DS, Jensen RH, Howard SJ, Goodwin J, Hope W.
    Antimicrob Agents Chemother; 2012 May; 56(5):2435-42. PubMed ID: 22354305
    [Abstract] [Full Text] [Related]

  • 8. Disseminated Candidiasis caused by Candida albicans with amino acid substitutions in Fks1 at position Ser645 cannot be successfully treated with micafungin.
    Slater JL, Howard SJ, Sharp A, Goodwin J, Gregson LM, Alastruey-Izquierdo A, Arendrup MC, Warn PA, Perlin DS, Hope WW.
    Antimicrob Agents Chemother; 2011 Jul; 55(7):3075-83. PubMed ID: 21502627
    [Abstract] [Full Text] [Related]

  • 9. Paradoxical antifungal activity and structural observations in biofilms formed by echinocandin-resistant Candida albicans clinical isolates.
    Walraven CJ, Bernardo SM, Wiederhold NP, Lee SA.
    Med Mycol; 2014 Feb; 52(2):131-139. PubMed ID: 24576999
    [Abstract] [Full Text] [Related]

  • 10. Increasing echinocandin resistance in Candida glabrata: clinical failure correlates with presence of FKS mutations and elevated minimum inhibitory concentrations.
    Alexander BD, Johnson MD, Pfeiffer CD, Jiménez-Ortigosa C, Catania J, Booker R, Castanheira M, Messer SA, Perlin DS, Pfaller MA.
    Clin Infect Dis; 2013 Jun; 56(12):1724-32. PubMed ID: 23487382
    [Abstract] [Full Text] [Related]

  • 11. Echinocandin resistance due to simultaneous FKS mutation and increased cell wall chitin in a Candida albicans bloodstream isolate following brief exposure to caspofungin.
    Imtiaz T, Lee KK, Munro CA, MacCallum DM, Shankland GS, Johnson EM, MacGregor MS, Bal AM.
    J Med Microbiol; 2012 Sep; 61(Pt 9):1330-1334. PubMed ID: 22653922
    [Abstract] [Full Text] [Related]

  • 12. Understanding Echinocandin Resistance in the Emerging Pathogen Candida auris.
    Kordalewska M, Lee A, Park S, Berrio I, Chowdhary A, Zhao Y, Perlin DS.
    Antimicrob Agents Chemother; 2018 Jun; 62(6):. PubMed ID: 29632013
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Specific substitutions in the echinocandin target Fks1p account for reduced susceptibility of rare laboratory and clinical Candida sp. isolates.
    Park S, Kelly R, Kahn JN, Robles J, Hsu MJ, Register E, Li W, Vyas V, Fan H, Abruzzo G, Flattery A, Gill C, Chrebet G, Parent SA, Kurtz M, Teppler H, Douglas CM, Perlin DS.
    Antimicrob Agents Chemother; 2005 Aug; 49(8):3264-73. PubMed ID: 16048935
    [Abstract] [Full Text] [Related]

  • 16. Spontaneous Mutational Frequency and FKS Mutation Rates Vary by Echinocandin Agent against Candida glabrata.
    Shields RK, Kline EG, Healey KR, Kordalewska M, Perlin DS, Nguyen MH, Clancy CJ.
    Antimicrob Agents Chemother; 2019 Jan; 63(1):. PubMed ID: 30373796
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.